---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-24-000035"
form_type: "8-K"
ticker: "ENTXW"
cik: "0001638097"
company_name: "Entera Bio Ltd."
filed_at: "2024-01-03T23:59:59+00:00"
generated_at: "2026-06-07T04:42:30.812431+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Entera Bio receives 180-day Nasdaq extension to June 24, 2024 to meet $1.00 bid price rule

## Summary
- Nasdaq granted 180-day extension on Dec 27, 2023; new compliance deadline is June 24, 2024.
- Must maintain closing bid price of at least $1.00 for 10 consecutive business days.
- Company may pursue reverse stock split to regain compliance.
- Failure to comply by June 24, 2024 could lead to delisting; trading continues for now.
- Extended period has no immediate effect on listing or trading under symbol ENTX.

## SEC filing metadata
- accession: 0001178913-24-000035
- form_type: 8-K
- ticker: ENTXW
- cik: 0001638097
- company_name: Entera Bio Ltd.
- filed_at: 2024-01-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638097/000117891324000035/0001178913-24-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638097/000117891324000035/zk2430720.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-24-000035
- JSON: https://secwatch.observer/filing/0001178913-24-000035.json
- Plain text: https://secwatch.observer/filing/0001178913-24-000035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.